Should bone marrow transplantation be included in the primary therapy of patients with aggressive lymphoma?

James O. Armitage

doi:10.3109/10428199209061554

Should bone marrow transplantation be included in the primary therapy of patients with aggressive lymphoma?

Research output: Contribution to journal › Article › peer-review

Abstract

Bone marrow transplantation is an increasingly. widely applied treatment for patients with non-Hodgkin's lymphoma and Hodgkin's disease¹. It is estimated that approximately 3,000-4,000 autologous transplants will be performed worldwide in 1991. The disease most frequently treated will be non-Hodgkin's lymphoma.

Original language	English (US)
Pages (from-to)	1-2
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	7
Issue number	S1
DOIs	https://doi.org/10.3109/10428199209061554
State	Published - 1992

Keywords

Bone marrow transplantation
Non-Hodgkin's lymphoma

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428199209061554

Cite this

@article{91eaa7a55da24e6cac72a422b0f9f018,

title = "Should bone marrow transplantation be included in the primary therapy of patients with aggressive lymphoma?",

abstract = "Bone marrow transplantation is an increasingly. widely applied treatment for patients with non-Hodgkin's lymphoma and Hodgkin's disease1. It is estimated that approximately 3,000-4,000 autologous transplants will be performed worldwide in 1991. The disease most frequently treated will be non-Hodgkin's lymphoma.",

keywords = "Bone marrow transplantation, Non-Hodgkin's lymphoma",

author = "Armitage, {James O.}",

year = "1992",

doi = "10.3109/10428199209061554",

language = "English (US)",

volume = "7",

pages = "1--2",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",